Lately, the world has faced tremendous progress in the understanding of non-alcoholic fatty
liver disease (NAFLD) pathogenesis due to rising obesity rates. Peroxisome proliferator …

Nonalcoholic fatty liver disease (NAFLD), a form of chronic liver disease that occurs in
individuals with no significant alcohol abuse, has become an increasing concern for global …

Non-alcoholic fatty liver disease (NAFLD) is a major health issue worldwide, frequently
associated with obesity and type 2 diabetes. Steatosis is the initial stage of the disease …

Nonalcoholic fatty liver disease (NAFLD) is one of the most common liver diseases
worldwide. In addition to the liver-related morbidity and mortality, NAFLD is now also …

Nonalcoholic fatty liver disease (NAFLD) encompasses a range of liver pathology ranging
from simple steatosis to varying degrees of inflammation, hepatocyte injury and fibrosis …

Non-alcoholic fatty liver disease (NAFLD), currently the leading cause of global chronic liver
disease, has emerged as a major public health problem, more efficient therapeutics of which …

Non-alcoholic fatty liver disease (NAFLD) is a liver pathology with increasing prevalence
due to the obesity epidemic. Hence, NAFLD represents a rising threat to public health …

Nonalcoholic fatty liver disease (NAFLD) is highly prevalent and can result in nonalcoholic
steatohepatitis (NASH) and progressive liver disease including cirrhosis and hepatocellular …

Non‐alcoholic fatty liver disease is becoming a major health burden, as prevalence
increases and there are no approved treatment options. Thiazolidinediones target the …

Non-alcoholic fatty liver disease (NAFLD) is a major health issue in developed countries.
Although usually associated with obesity, NAFLD is also diagnosed in individuals with low …